Stocks making the biggest moves in the premarket: Concho Resources, Halliburton, AstraZeneca & more
The stocks making the biggest moves in premarket trading include Concho Resources, Halliburton, AstraZeneca, and more. (Source: Reuters: Health)
Source: Reuters: Health - October 19, 2020 Category: Consumer Health News Source Type: news

AstraZeneca’s no-profit pledge for coronavirus vaccines may end in 2021
(Natural News) A memorandum of understanding between British pharmaceutical company AstraZeneca and Brazilian public health research institution Fiocruz obtained by The Financial Times stated the drugmaker has the right to declare the pandemic’s end by July 2021. Under the document’s terms, AstraZeneca will also be providing doses of its coronavirus vaccine – developed in tandem with... (Source: NaturalNews.com)
Source: NaturalNews.com - October 17, 2020 Category: Consumer Health News Source Type: news

AstraZeneca took ONE MONTH to give the FDA vaccine trial data after the study was paused
A new report says AstraZeneca just delivered coronavirus vaccine trial data to the FDA last week after the study was paused when a UK patient developed rare spinal complication. (Source: the Mail online | Health)
Source: the Mail online | Health - October 15, 2020 Category: Consumer Health News Source Type: news

3 Covid-19 Trials Have Been Paused for Safety. That ’s a Good Thing.
Experts were comforted that companies are following safety precautions. They pointed out that pauses in vaccine trials are common, but pauses in treatment trials like Eli Lilly ’s are rare. (Source: NYT Health)
Source: NYT Health - October 14, 2020 Category: Consumer Health News Authors: Carl Zimmer Tags: Clinical Trials Drugs (Pharmaceuticals) Coronavirus (2019-nCoV) Vaccination and Immunization AstraZeneca PLC Eli Lilly and Company Johnson & Regeneron Pharmaceuticals Inc your-feed-healthcare Source Type: news

Eli Lilly ’s Antibody Trial Is Paused Over Potential Safety Concern
The drugmaker ’s experimental antibody treatment is similar to the one President Trump received from Regeneron. (Source: NYT Health)
Source: NYT Health - October 14, 2020 Category: Consumer Health News Authors: Katherine J. Wu and Katie Thomas Tags: Clinical Trials Drugs (Pharmaceuticals) Coronavirus (2019-nCoV) Eli Lilly and Company Johnson & AstraZeneca PLC your-feed-healthcare Source Type: news

Thailand to Make, Supply AstraZeneca's COVID-19 Vaccine Thailand to Make, Supply AstraZeneca's COVID-19 Vaccine
Thailand has agreed to manufacture and supply AstraZeneca Plc's experimental COVID-19 vaccine in the southeast Asian country and other nations in the region, the British and Thai governments said on Monday.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - October 13, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Johnson & Johnson Pauses Coronavirus Vaccine Trial Over Unexplained Illness
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p0").init({"mcp":"cbs","width":"100%","height":"100%","video":"4784870","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p0","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 13, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Covid-19 Boston, MA Health Healthcare Status Beth Israel Deacones Medical Center Coronavirus Johnson & Johnson Source Type: news

A Second COVID-19 Vaccine Trial Has Been Paused Over an Unexplained Illness
NEW BRUNSWICK, N.J. — A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot. The company said in a statement Monday evening that illnesses, accidents and other so-called adverse events “are an expected part of any clinical study, especially large studies,” but that its physicians and a safety monitoring panel would try to determine what might have caused the illness. The pause is at least the second such hold to occur among several vaccines th...
Source: TIME: Health - October 13, 2020 Category: Consumer Health News Authors: Associated Press Tags: Uncategorized COVID-19 overnight wire Source Type: news

Covid-19 vaccines not near, trials just started
The first batch of 100 participants in the Indian trial of the vaccine developed by University of Oxford and AstraZeneca were inoculated on October 8. Serum Institute of India (SII) is conducting the trials. Results of trials of Oxford and Bharat Biotech won ’t be out till 2021. (Source: The Economic Times)
Source: The Economic Times - October 13, 2020 Category: Consumer Health News Source Type: news

COVID-19 Long-Acting AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials
AstraZeneca's long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in and outside the US that are due to begin in the next weeks. The LAABs have been engineered with AstraZeneca's proprietary half-life extension technology to increase the durability of the therapy for six to 12 months following a single administration. (Source: World Pharma News)
Source: World Pharma News - October 9, 2020 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

Trump ’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue
The “cell lines” used to develop monoclonal antibodies, as well as remdesivir and vaccines, began with fetal tissue decades ago. (Source: NYT Health)
Source: NYT Health - October 9, 2020 Category: Consumer Health News Authors: Apoorva Mandavilli and Nathalia Holt Tags: your-feed-science United States Politics and Government Fetal Tissue Coronavirus (2019-nCoV) Abortion Vaccination and Immunization Antibodies Ethics and Official Misconduct Drugs (Pharmaceuticals) AstraZeneca PLC Eli Lilly and Company Source Type: news

AstraZeneca vaccine document shows limit of no-profit pledge
Company has right under contract to declare pandemic over by July 2021 (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - October 7, 2020 Category: Pharmaceuticals Source Type: news

Oxford University coronavirus vaccine could be rolled out within six months: Report
The vaccine candidate under trial by University of Oxford scientists in collaboration with pharmaceutical giant AstraZeneca is the furthest in the process of trials and, according to a report in ‘The Times', it could be given the required clearances by Christmas in December. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 2, 2020 Category: Pharmaceuticals Source Type: news

EU Regulator Launches Real-Time Review of AstraZeneca's COVID-19 Vaccine EU Regulator Launches Real-Time Review of AstraZeneca's COVID-19 Vaccine
The European health regulator has started reviewing data on AstraZeneca and Oxford University's potential COVID-19 vaccine in real time.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - October 2, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

FDA Widens US Safety Inquiry Into AstraZeneca Coronavirus Vaccine: Sources FDA Widens US Safety Inquiry Into AstraZeneca Coronavirus Vaccine: Sources
The FDA has broadened its investigation of a serious illness in AstraZeneca's COVID-19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - October 2, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India
The Phase I/II clinical trial for the COVID-19 vaccine AZD1222 has resumed in Japan after discussion with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). A standard review process triggered a voluntary pause to vaccination across all global trials on 6 September to allow review of safety data by an independent committee. (Source: World Pharma News)
Source: World Pharma News - October 2, 2020 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news

EU agency starts 'rolling review' to speed OK for vaccine
The European Medicines Agency has begun its first review process for the COVID-19 vaccine being developed by Oxford University and AstraZeneca (Source: ABC News: Health)
Source: ABC News: Health - October 1, 2020 Category: Consumer Health News Tags: Health Source Type: news

FDA widens probe into AstraZeneca Covid vaccine
Europe readies rolling reviews of potential jabs as US broadens inquiry into adverse reaction (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - October 1, 2020 Category: Pharmaceuticals Source Type: news

Myelitis observed in two COVID-19 vaccine trial participants is a common vaccine injury
(Natural News) The makers of the frontrunner COVID-19 vaccine, AstraZeneca and Oxford University, were quick to downplay the illness that caused their clinical trials in five countries to come to a screeching halt earlier in September. However, the condition at the heart of the move, transverse myelitis, is actually a fairly common vaccine injury. The... (Source: NaturalNews.com)
Source: NaturalNews.com - September 30, 2020 Category: Consumer Health News Source Type: news

UK doing more than most to help poor get Covid vaccine, study finds
Campaign scoring countries for global access efforts calls for more British transparencyCoronavirus – latest updatesSee all our coronavirus coverageThe UK is doing more than most countries to support access to Covid vaccines for the poorest populations in the world, but it is not transparent enough about the deals it is doing at home, according to an international aid organisation launching a tracker.The One campaign has given countries and pharmaceutical companies scores for the efforts they have made to ensure the poorest get vaccines. In the vaccine access test no country or company scores green, the top rating, c...
Source: Guardian Unlimited Science - September 30, 2020 Category: Science Authors: Sarah Boseley Health editor Tags: Coronavirus outbreak Health policy Politics Society UK news Medical research Infectious diseases Public services policy Science World news Pharmaceuticals industry AstraZeneca Business Microbiology Global development Vaccines Source Type: news

Will Pfizer's Vaccine Be Ready in October? Here's Why That's Unlikely.
Despite slim chances that its vaccine will be ready by October, Pfizer has big incentives to hint that it might be. (Source: NYT Health)
Source: NYT Health - September 30, 2020 Category: Consumer Health News Authors: Katie Thomas Tags: Pfizer Inc Coronavirus (2019-nCoV) Vaccination and Immunization Bourla, Albert your-feed-science Clinical Trials Drugs (Pharmaceuticals) United States Politics and Government AstraZeneca PLC Food and Drug Administration Johnson & M Source Type: news

The world should get a COVID-19 vaccine by early 2021, says Microsoft founder Bill Gates
"I am optimistic that by early next year, of the six western constructs, probably three or four will have shown safety and efficacy, and four of those can be made at large scale and low cost, including AstraZeneca, Johnson& Johnson, Novavax and Sanofi," the co-chair of the Bill and Melinda Gates foundation told the ET Global Business Summit. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 23, 2020 Category: Pharmaceuticals Source Type: news

SBI, Theragnostics ink oral cancer technology deal
Molecular radiotherapy developer Theragnostics and Summit Biomedical Imaging...Read more on AuntMinnie.comRelated Reading: GE, Theragnostics partner on PSMA agent Theragnostics inks AstraZeneca agreement (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 23, 2020 Category: Radiology Source Type: news

J & J ’s COVID-19 Vaccine Will Enter Phase 3 Testing, the Fourth To Reach That Stage
Johnson & Johnson announced today (Sept. 23) that it is launching a large-scale Phase 3 test of its COVID-19 vaccine candidate, which was developed based on science supported by the National Institutes of Health. The vaccine, being tested through the company’s Janssen Pharmaceuticals arm, will be the fourth to enter late stage studies, following candidates from Moderna, Pfizer-BioNTech and AstraZeneca. Unlike those vaccine candidates, which all require two shots, J&J’s vaccine involves a single injection. That means it could require half the number of doses to immunize the same number of people. J&J...
Source: TIME: Health - September 23, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Johnson & Johnson ’ s Coronavirus Vaccine Enters Phase 3 Trial With Beth Israel
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p1").init({"mcp":"cbs","width":"100%","height":"100%","video":"4730668","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p1","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 23, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Covid-19 Boston, MA Health Healthcare Status Beth Israel Deacones Medical Center Coronavirus Johnson & Johnson Source Type: news

Second AstraZeneca trial participant develops rare neurological condition following COVID-19 vaccination
(Natural News) It has come to our attention that a second participant in AstraZeneca’s Wuhan coronavirus (COVID-19) vaccine trials has come down with a serious neurological condition that the company claims is not at all related to the volunteer getting vaccinated. Just like the first participant, who we reported developed severe spinal inflammation, this second... (Source: NaturalNews.com)
Source: NaturalNews.com - September 22, 2020 Category: Consumer Health News Source Type: news

Three COVID Vaccine Developers Release Detailed Trial Protocols Three COVID Vaccine Developers Release Detailed Trial Protocols
Apparently bowing to pressure to be more transparent, AstraZeneca, Moderna, and Pfizer/BioNTech each released details of their vaccine trial protocols.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - September 22, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

What Your Blood Tells You About Cancer
Blood tests can tell us a lot about what’s going on in our bodies—from whether we’re eating too much sugar to whether we’re harboring any infectious diseases. Scientists lately have been working on ways to use similar diagnostic tools for cancer, which have the potential to dramatically increase the amount of information doctors use to figure out the best treatments for their patients. Called liquid biopsies, these tests are designed to pick up genetic material shed by cancer tumors into the blood, which lets doctors avoid the invasive procedures needed to extract samples directly from tumors. That ...
Source: TIME: Health - September 22, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Source Type: news

AstraZeneca Releases COVID - 19 Vaccine Trial Plans
Serious neurological illnesses have led the company to halt its trials twice (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 22, 2020 Category: Respiratory Medicine Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pathology, Pharmacy, Pulmonology, Institutional, Source Type: news

AstraZeneca Releases COVID-19 Vaccine Trial Plans
MONDAY, Sept. 21, 2020 -- AstraZeneca is the latest drug company to release details about human tests of its COVID-19 vaccine in response to public demand for such information. Americans have increasing doubts about a COVID-19 vaccine, and experts... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 21, 2020 Category: Pharmaceuticals Source Type: news

October issue of SLAS Discovery now available
(SLAS (Society for Laboratory Automation and Screening)) The October edition of SLAS Discovery features the cover article, 'A Critical and Concise Review of Mass Spectrometry Applied to Imaging in Drug Discovery' by Richard J. A. Goodwin Ph.D. (AstraZeneca), Zoltan Takats Ph.D. (Imperial College London), and Josephine Bunch, Ph.D. (National Physical Laboratory). (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 21, 2020 Category: Biology Source Type: news

Highmark, AstraZeneca Enter Outcomes-Based Agreement for Severe Asthma...
Highmark announced that it has entered an outcomes-based agreement with AstraZeneca for Fasenra, an add-on prescription maintenance treatment for patients age 12 or older with severe asthma. Through...(PRWeb September 21, 2020)Read the full story at https://www.prweb.com/releases/highmark_astrazeneca_enter_outcomes_based_agreement_for_severe_asthma_medication_fasenra/prweb17392252.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 21, 2020 Category: Pharmaceuticals Source Type: news

AstraZeneca Releases Blueprints for Virus Vaccine Trial Amid Safety Scrutiny
A surge of infections in the Southwest and the Midwest is partly driving an uptick in cases nationally. The eight remaining members of the Supreme Court are expected to hear arguments next month via telephone. (Source: NYT Health)
Source: NYT Health - September 20, 2020 Category: Consumer Health News Tags: Coronavirus (2019-nCoV) Source Type: news

AstraZeneca, Under Fire for Vaccine Safety, Releases Trial Blueprints
Experts are concerned that the company has not been more forthcoming about two participants who became seriously ill after getting its experimental vaccine. (Source: NYT Health)
Source: NYT Health - September 19, 2020 Category: Consumer Health News Authors: Denise Grady, Katherine J. Wu and Sharon LaFraniere Tags: Clinical Trials Vaccination and Immunization Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) AstraZeneca PLC Source Type: news

AstraZeneca, under fire for coronavirus vaccine safety, releases trial blueprints
Polls are finding Americans increasingly wary of accepting a coronavirus vaccine. And scientists inside and outside the government are worried that regulators, pressured by the president for results before Election Day on Nov. 3, might release an unproven or unsafe vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 19, 2020 Category: Pharmaceuticals Source Type: news

Phase-III trial of Oxford vaccine to begin in Pune next week
The SII has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford. (Source: The Economic Times)
Source: The Economic Times - September 18, 2020 Category: Consumer Health News Source Type: news

How to Ship a Vaccine at –80°C, and Other Obstacles in the Covid Fight
Developing an effective vaccine is the first step. Then comes the question of how to deliver hundreds of millions of doses that may need to be kept at arctic temperatures. (Source: NYT Health)
Source: NYT Health - September 18, 2020 Category: Consumer Health News Authors: David Gelles Tags: Vaccination and Immunization Coronavirus (2019-nCoV) Ice Shortages Carbon Dioxide AstraZeneca PLC BioNTech SE Centers for Disease Control and Prevention Corning Inc Fedex Corporation Moderna Inc Pfizer Inc United Parcel Service Inc Source Type: news

Details Emerge on Unexplained Illness in AstraZeneca COVID - 19 Vaccine Trial
Healthy 37 - year - old woman'experienced confirmed transverse myelitis'after receiving second dose of vaccine (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 18, 2020 Category: Respiratory Medicine Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Critical Care, Emergency Medicine, Neurology, Nursing, Pharmacy, Pulmonology, Institutional, Source Type: news

We Need a COVID-19 Vaccine. We Also Need Transparency About Its Development
The authorization of an effective vaccine will mark perhaps the biggest turning point in the battle against coronavirus, but only if enough people are willing to get vaccinated. There have been substantial declines in public willingness to get vaccinated against COVID-19, despite immense, unprecedented public investments in vaccine development. In one survey, barely half of Americans said they would get the vaccine as soon as it was available, numbers that will undermine the benefits of even a highly effective vaccine. It is no mystery why trust in a potential vaccine has plummeted. Operation Warp Speed, the Trump Administ...
Source: TIME: Health - September 18, 2020 Category: Consumer Health News Authors: Dr. Ashish K. Jha Tags: Uncategorized COVID-19 Source Type: news

Details Emerge on Unexplained Illness in AstraZeneca COVID-19 Vaccine Trial
FRIDAY, Sept. 18, 2020 -- New details surfaced on Thursday on an unexplained neurological condition that struck a volunteer who was participating in AstraZeneca's COVID-19 vaccine trial. In an internal safety report obtained by CNN, company... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 18, 2020 Category: Pharmaceuticals Source Type: news

Details Emerge on Unexplained Illness in AstraZeneca COVID Vaccine Trial
FRIDAY, Sept. 18, 2020 (Healthday News) -- New details surfaced on Thursday on an unexplained neurological condition that struck a volunteer who was participating in AstraZeneca's coronavirus vaccine trial. In an internal safety report obtained by... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 18, 2020 Category: General Medicine Source Type: news

When Will You Be Able to Get a Coronavirus Vaccine?
Despite the president ’s repeated claims that a vaccine will be available in October, scientists, companies and federal officials all say that most people won’t get one until well into next year. (Source: NYT Health)
Source: NYT Health - September 18, 2020 Category: Consumer Health News Authors: Katie Thomas and Jesse Drucker Tags: Clinical Trials Shortages Vaccination and Immunization Coronavirus (2019-nCoV) United States Politics and Government AstraZeneca PLC Advisory Committee on Immunization Practices Centers for Disease Control and Prevention Food and Drug Admi Source Type: news

Illness In Paused AstraZeneca Trial Likely Wasn ’t Caused By Vaccine, Oxford University Says
“After independent review, these illnesses were either considered unlikely to be associated with the vaccine or there was insufficient evidence to say for certain that the illnesses were or were not related to the vaccine.” (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 16, 2020 Category: Pharmaceuticals Authors: Rachel Sandler, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Source Type: news

Some Volunteers Quit J & J COVID-19 Trial in Spain After AstraZeneca Scare: Investigator Some Volunteers Quit J & J COVID-19 Trial in Spain After AstraZeneca Scare: Investigator
Some volunteers have quit Johnson& Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 16, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

US FDA's Hahn Plans'Significant' Work With AstraZeneca in COVID-19 Trial Inquiry US FDA's Hahn Plans'Significant' Work With AstraZeneca in COVID-19 Trial Inquiry
The top US Food and Drug Administration official on Tuesday confirmed AstraZeneca's US COVID-19 vaccine trial is on hold.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 16, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Brazil Authorizes Additional 5000 Volunteers for AstraZeneca COVID-19 Vaccine Brazil Authorizes Additional 5000 Volunteers for AstraZeneca COVID-19 Vaccine
Brazil's health regulator Anvisa on Tuesday authorized AstraZeneca to test its COVID-19 vaccine on an additional 5000 volunteers in the country for clinical Phase 3 trials.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 16, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

Paused AstraZeneca Trials Emphasize Need For Vaccine Transparency
AstraZeneca, and all the other companies under Food and Drug Administration purview, are developing vaccines for Covid-19. In the midst of current trials across the globe, they paused operation when a participant in the United Kingdom developed symptoms of a spinal inflammatory disease. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 16, 2020 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus business pharma & Source Type: news

Australia ’s field force: evolving on fast forward
The pandemic has, it will surprise no one, upended traditional ways of working for pharma ’s Australian field force. “I don't think that we will ever go back to working the way we did pre-COVID, ” says David Grolman, Medical Director at Pfizer Australia and New Zealand.”   But arguably this is less of a revolution than it might first seem. The havoc and disruption it has wreaked has merely accelerated change that was happening anyway, much of it positive, says Matthew Britland, VP of the Australian Pharmaceutical medical and scientific Professionals Association (APPA). “It’s c...
Source: EyeForPharma - September 16, 2020 Category: Pharmaceuticals Authors: Lucy Fulford Source Type: news

US regulators are 'very concerned' about the side effects of AstraZeneca's vaccine
US regulators have not allowed AstraZeneca's vaccine trial to resume in America and first want to determine if the jab or another factor caused a UK participant to suffer spinal cord inflammation. (Source: the Mail online | Health)
Source: the Mail online | Health - September 15, 2020 Category: Consumer Health News Source Type: news